SCHEMBL8987344

SCHEMBL8987344

Cc1ccc2[nH]c(=O)cc(-c3ccccc3)c2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.67
SMN1; SMN2 Q16637 4/20 0.67
MEN1 O00255 3/20 0.67
KMT2A Q03164 3/20 0.67
HTT P42858 3/20 0.67
MAPK1 P28482 1/20 0.67
RXFP1 Q9HBX9 1/20 0.67
KDM4E B2RXH2 7/20 0.60
HSD17B10 Q99714 3/20 0.60
NPC1 O15118 2/20 0.60
LMNA P02545 2/20 0.60
TP53 P04637 1/20 0.60
MAPT P10636 1/20 0.60
RAB9A P51151 1/20 0.60
BRD4 O60885 2/20 0.58
POLB P06746 2/20 0.54
ALDH1A1 P00352 5/20 0.54
GFER P55789 2/20 0.54
TNKS2 Q9H2K2 2/20 0.51
CYP1A2 P05177 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28133664 1.00 HPGD (0.67) HPGDSMN1; SMN2MEN1KMT2AHTT
SCHEMBL8987099 0.87 HPGD (0.67) HPGDSMN1; SMN2MEN1KMT2AHTT
SCHEMBL16814402 0.84 KDM4E (0.55) HPGDSMN1; SMN2MEN1KMT2AHTT
SCHEMBL9522235 0.83 HPGD (0.58) HPGDSMN1; SMN2MEN1KMT2AHTT
SCHEMBL8986955 0.81 HPGD (0.74) HPGDSMN1; SMN2MEN1KMT2AHTT
SCHEMBL28133652 0.80 HPGD (1.00) HPGDSMN1; SMN2MEN1KMT2AHTT
SCHEMBL1173520 0.80 HPGD (1.00) HPGDSMN1; SMN2MEN1KMT2AHTT
SCHEMBL29612166 0.80 HPGD (1.00) HPGDSMN1; SMN2MEN1KMT2AHTT
SCHEMBL23674195 0.80 HPGD (0.67) HPGDSMN1; SMN2MEN1KMT2AHTT
SCHEMBL12277483 0.80 RXFP1 (0.67) HPGDSMN1; SMN2MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5492915-A ANTIINFLAMMATORY AGENTS RHONE-POULENC RORER S.A. (FR) 1996-02-20 US disclosed
US-5366982-A Antiinflammatory agents or antihistamines RHONE-POULENC RORER S.A. (FR) 1994-11-22 US disclosed
EP-0540604-A1 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS Aventis Pharma S.A. (FR) 1993-05-12 EP disclosed
WO-1992001675-A2 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS RHONE-POULENC RORER S.A. (FR) 1992-02-06 WO disclosed